Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health, has announced topline results of its pivotal trial of the Osteoboost Vibration Belt. The results found that using Osteoboost more than three ...
Ionis Pharmaceuticals has announced that the European Medicines Agency (EMA) has accepted the marketing authorization application (MAA) for review of tofersen, an investigational medicine for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). ...
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for revumenib for the treatment of ...
Popular Posts
